EUR 26.0
(0.0%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 85.13 Million | 124.67 Million | 68.94 Million | 69.19 Million | 31.52 Million | 52.32 Million |
Net Income | 61.9 Million | 45.63 Million | 39.34 Million | 41.27 Million | 38.4 Million | 27.67 Million |
Depreciation & Amortization | 55.17 Million | 35.27 Million | 27.36 Million | 20.37 Million | 14.12 Million | 13.51 Million |
Deferred income taxes | -1.33 Million | 1.21 Million | 3.43 Million | -18.07 Million | -2.22 Million | -1.46 Million |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -58.39 Million | 44.96 Million | -15.66 Million | -355.2 Thousand | -12.33 Million | 4.7 Million |
Other non-cash items | 158.79 Million | -1.19 Million | 17.9 Million | 7.9 Million | -8.67 Million | 11.13 Million |
Investing Cash Flow | -22.12 Million | -139.3 Million | -85.52 Million | -114.58 Million | -68.2 Million | -28.01 Million |
Investments in PPE | -65.46 Million | -73.78 Million | -49.69 Million | -71.44 Million | -44.95 Million | -28.59 Million |
Acquisitions | -10.91 Million | -43.05 Million | -5.48 Million | 36.5 Thousand | 942.29 Thousand | 1.91 Million |
Investment purchases | -9.84 Million | -42.03 Million | -53.58 Million | -43.25 Million | -24.14 Million | -1.39 Million |
Sales/Maturities of investments | 65.39 Million | 5.62 Million | 20.73 Million | 750 Thousand | -942.29 Thousand | 65.67 Thousand |
Other Investing Activities | -1.28 Million | 13.94 Million | 2.5 Million | -668.44 Thousand | 903.59 Thousand | -1.65 Million |
Financing Cash Flow | -53.26 Million | -20.36 Million | 119.55 Million | 26.38 Million | 77.5 Million | -2.5 Million |
Debt repayment | -8.53 Million | -61.35 Million | -44.44 Million | -33.62 Million | -24.58 Million | -765.2 Thousand |
Dividends payments | -30.8 Million | -28.47 Million | -21.31 Million | -16.9 Million | -30 Million | -4.7 Million |
Common Stock Repurchased | -20.9 Million | -695.87 Thousand | -4.75 Million | -3.61 Million | - | - |
Common Stock Issuance | -5.41 Million | - | 107.03 Million | 2.1 Million | 101.64 Million | - |
Other Financing Activities | -4.68 Million | 70.15 Million | 83.03 Million | 78.41 Million | 30.43 Million | 1.43 Million |
Accounts receivables | -32.34 Million | -26.6 Million | -7.08 Million | -6.57 Million | 129.2 Thousand | -3094.00 |
Accounts payables | 31.8 Million | 61.1 Million | 17.71 Million | 2.81 Million | -15.18 Million | -5.25 Million |
Inventory | -20.12 Million | -4.78 Million | -6.16 Million | -3.28 Million | -6.23 Million | 7.78 Million |
Other working capital | -37.74 Million | 15.25 Million | -20.13 Million | 6.69 Million | 8.95 Million | 2.17 Million |
Cash at beginning of period | 135.24 Million | 166.17 Million | 63.19 Million | 82.2 Million | 41.33 Million | 19.51 Million |
Cash at end of period | 140.92 Million | 131.18 Million | 166.17 Million | 63.19 Million | 82.15 Million | 41.33 Million |
Capital Expenditure | -65.46 Million | -73.78 Million | -49.69 Million | -71.44 Million | -44.95 Million | -28.59 Million |
Effect of forex changes on cash | -4.06 Million | - | - | - | 1.00 | - |
Net cash flow / Change in cash | 5.68 Million | -34.99 Million | 102.97 Million | -19 Million | 40.82 Million | 21.81 Million |
Free Cash Flow | 19.67 Million | 50.88 Million | 19.24 Million | -2.25 Million | -13.42 Million | 23.73 Million |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 18.8 Million | 16.18 Million | 61.9 Million | 10.85 Million | 20.02 Million | 16.76 Million |
Depreciation & Amortization | - | - | 55.17 Million | - | 11.16 Million | 14.83 Million |
Deferred income taxes | - | - | -1.33 Million | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | -58.39 Million | - | - | - |
Other non-cash items | -18.8 Million | -16.18 Million | 158.79 Million | -10.85 Million | -20.02 Million | -16.76 Million |
Investing Cash Flow | - | - | -22.12 Million | - | - | - |
Investments in PPE | - | - | -65.46 Million | - | - | - |
Acquisitions | - | - | -10.91 Million | - | - | - |
Investment purchases | - | - | -9.84 Million | - | - | - |
Sales/Maturities of investments | - | - | 65.39 Million | - | - | - |
Other Investing Activities | - | - | -1.28 Million | - | - | - |
Financing Cash Flow | - | - | -53.26 Million | - | - | - |
Debt repayment | - | - | -8.53 Million | - | - | - |
Dividends payments | - | - | -30.8 Million | - | - | - |
Common Stock Repurchased | - | - | -20.9 Million | - | - | - |
Common Stock Issuance | - | - | -5.41 Million | - | - | - |
Other Financing Activities | - | - | -4.68 Million | - | - | - |
Accounts receivables | - | - | -32.34 Million | - | - | - |
Accounts payables | - | - | 31.8 Million | - | - | - |
Inventory | - | - | -20.12 Million | - | - | - |
Other working capital | - | - | -37.74 Million | - | - | - |
Cash at beginning of period | - | - | 135.24 Million | - | 117.18 Million | 113.33 Million |
Cash at end of period | - | - | 140.92 Million | - | 64.54 Million | 117.18 Million |
Capital Expenditure | - | - | -65.46 Million | - | - | - |
Effect of forex changes on cash | - | - | -4.06 Million | - | - | - |
Net cash flow / Change in cash | - | - | 5.68 Million | - | -52.64 Million | 3.85 Million |
Free Cash Flow | - | - | 19.67 Million | - | 22.33 Million | 29.66 Million |
INDIAGLYCO
0KC4
PIDILITIND
9986
0HWG
SMBR